Department of Internal Medicine, National Hospital Organization Tochigi Medical Center, 1-10-37, Nakatomatsuri, Utsunomiya, Tochigi, 3208580, Japan.
Department of Pediatric Surgery, National Hospital Organization Tochigi Medical Center, 1-10-37, Nakatomatsuri, Utsunomiya, Tochigi, 3208580, Japan.
BMC Geriatr. 2017 Dec 16;17(1):288. doi: 10.1186/s12877-017-0681-3.
Polypharmacy is frequently observed in hip fracture patients. Although it is associated with an increased risk of hip fracture, polypharmacy often continues after hip fracture recovery. This study aimed to evaluate the effectiveness of an intervention to improve appropriate polypharmacy for elderly patients admitted to the hospital for hip fractures.
We conducted a retrospective observational study to compare the outcomes of patients receiving the intervention (n = 32) with those of patients who received usual care (n = 132). All hip fracture patients aged 65 years or older and prescribed 5 or more medications at admission from January 2015 to December 2016 were included in the study. The intervention consisted of an assessment by internal medicine physicians of the appropriateness of polypharmacy and the de-prescription of any unnecessary medications during the patients' hospital stay. The primary composite outcome was death or the first occurrence of any new fracture. Comparisons between the intervention and usual care groups were analyzed using binary logistic regression.
A total of 164 patients were included in the study. The mean patient age was 84.8 years, and the mean numbers of prescribed medications and potentially inappropriate medications at admission were 8.0 and 1.3, respectively. The mean follow-up period was 8.0 months. The primary composite outcome occurred in 35 (21.3%) patients. The total number of potentially inappropriate medications at discharge was significantly lower in the intervention group than in the usual care group (0.8 ± 0.8 for the intervention group vs 1.1 ± 1.0 for the usual care group; p = 0.03). However, no significant differences in the primary composite outcome were found between the intervention and usual care groups (7 in the intervention group and 28 in the usual care group, odds ratio 1.04, 95% CI 0.41-2.65; p = 1.00).
The intervention to improve appropriate polypharmacy was associated with a reduction in potentially inappropriate medications but not an improvement in clinical outcomes. This intervention, which focused only on polypharmacy, may not effectively improve outcomes for elderly patients with hip fractures.
UMIN-CTR UMIN000025495 . Retrospectively registered 2 January 2017.
在髋部骨折患者中经常观察到多种药物治疗。尽管它与髋部骨折风险增加有关,但髋部骨折恢复后,多种药物治疗往往仍在继续。本研究旨在评估一种干预措施对改善因髋部骨折住院的老年患者适当的多种药物治疗的效果。
我们进行了一项回顾性观察性研究,比较了接受干预(n=32)和接受常规治疗(n=132)的患者的结局。所有 2015 年 1 月至 2016 年 12 月因髋部骨折入院且入院时服用 5 种或以上药物的年龄≥65 岁的髋部骨折患者均纳入研究。干预措施包括内科医生评估多种药物治疗的适当性,并在患者住院期间减少任何不必要的药物。主要复合结局是死亡或任何新骨折的首次发生。使用二项逻辑回归分析干预组和常规治疗组之间的比较。
共纳入 164 例患者。患者平均年龄为 84.8 岁,入院时处方药物和潜在不适当药物的平均数量分别为 8.0 和 1.3。平均随访时间为 8.0 个月。主要复合结局在 35 例(21.3%)患者中发生。干预组出院时潜在不适当药物的总数明显低于常规治疗组(干预组 0.8±0.8,常规治疗组 1.1±1.0;p=0.03)。然而,干预组和常规治疗组之间主要复合结局无显著差异(干预组 7 例,常规治疗组 28 例,比值比 1.04,95%置信区间 0.41-2.65;p=1.00)。
改善适当的多种药物治疗的干预措施与减少潜在不适当药物有关,但与临床结局的改善无关。这种仅关注多种药物治疗的干预措施可能无法有效改善髋部骨折老年患者的结局。
UMIN-CTR UMIN000025495。2017 年 1 月 2 日回顾性注册。